Indraprastha Medical Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indraprastha Medical Corporation Ltd. on BSE

Search Inside the pdf :

Indraprastha Medical Corporation Ltd.

26 May 2025

448.65

1.92%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

we wish to inform you that Dr. Arum Rai ( DIN: 07159822) has completed his second five year term as Independent director in the company, on 25th May, 2025. Therefore he ceases to be director and member of the Audit Committee & Nomination & Remuneration Committee of the board, at end of the day on 25th may, 2025.

pdf

Indraprastha Medical Corporation Ltd.

23 May 2025

448.65

1.92%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

we hereby inform you that Dr Menaka Guruswamy ( DIN 08742679) has completed her tenure viz. first term of five (5) consecutive years on 22nd May, 2025, as Independent Director on the Board of directors of the Company. she has opted not to renew her second term as an independent Director, hence she ceased to be a director of the company at the end of the day on 22nd May, 2025.

pdf

Indraprastha Medical Corporation Ltd.

19 May 2025

448.65

1.92%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

we hereby submit annual secretarial l compliance report for the year ended 31st march,2025.

pdf

Indraprastha Medical Corporation Ltd.

17 May 2025

448.65

1.92%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

we hereby submit copies of the public notice of financial results, published on 17th May, 2025.

pdf

Indraprastha Medical Corporation Ltd.

16 May 2025

448.65

1.92%

Board Meeting

Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

This is to inform you that the Board of Directors of the company has, at its meeting held on Friday, 16th May, 2025 (i.e., Today), inter-alia: 1. Approved the Audited Financial Statements for the year ended 31st March,2025, and Audited Financial Results for the quarter/year ended 31st March, 2025, as recommended by the audit Committee; and, 2. Recommended a dividend @ 45% that is Rs 4.50 per share for the financial year 2024-2025.

pdf

Indraprastha Medical Corporation Ltd.

05 May 2025

448.65

1.92%

Board Meeting

Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Intimation for Board Meeting On 16Th May, …

BSE India

Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve This is to hereby inform you that meting of the Board of Directors of the Company will be held on Friday, 16th May, 2025, Inter Alia:- 1. to consider and approve the audited financial results for the quarter/year ended 31st march, 2025; and 2. to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2024-25.

pdf

Indraprastha Medical Corporation Ltd.

28 Apr 2025, 12:53PM

448.65

1.92%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

we wish to inform that ICRA Limited has: a) reaffirmed long-term - fund based - cash credit rating of {ICRA}AA (pronounced ICRA Double A) for Rs. 32.50 crore and short- term - non fund based rating of {ICRA}A1+ (pronounced ICRA A One Plus) for Rs. 30 crore bank facilities: and, b) assigned long term- fund based - term loan credit rating, of {ICRA}AA (pronounced ICRA Double A) for Rs. 100 crore, to the company. This is for your information and record.

pdf

Indraprastha Medical Corporation Ltd.

28 Apr 2025, 12:45PM

448.65

1.92%

Corp. Note

Indraprastha Medical Corporation Ltd - 532150 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyIndraprastha Medical Corporation Ltd 2CIN NO.L24232DL1988PLC030958 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PRIYA RANJAN Designation: AVP CORPORATE AFFAIRS LEGAL EmailId: priya_ranjan@apollohospitals.com Name of the Chief Financial Officer: C P TYAGI Designation: CFO EmailId: tyagi@apollohospitals.com Date: 28/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Indraprastha Medical Corporation Ltd.

09 Apr 2025

448.65

1.92%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Enclosed please find herewith, a certificate dated 02-04-2025, issued by RTA of the company for the quarter ended 31-03-2025.. this is for your information & record.

pdf

Indraprastha Medical Corporation Ltd.

24 Mar 2025

448.65

1.92%

SAST

Indraprastha Medical Corporation Ltd - 532150 - Closure of Trading Window

BSE India

it is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons including promoters, directors, key managerial personnel ,designated employees and their connected persons from Tuesday, 1st April, 2025 until 48 hours after declaration of audited Financial Results by the the Company, for year ending 31st March, 2025.

pdf

Is Indraprastha Medical Corporation Ltd. worth buying?

260 Votes:

Buy 80.0%

Sell 14.62%

Hold 5.38%

RESEARCH REPORTS

112.33% Gain from 52W Low

Indraprastha Medical Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indraprastha Medical Corporation Ltd. on BSE

No research report for Indraprastha Medical Corporation Ltd.